EDWARDS LIFESCIENCES CORP
EDWARDS LIFESCIENCES CORP/ US28176E1082 /
EWLS
|
15/11/2024 13:00:32
|
Diferencia
-1.37
|
Volumen |
Bid15:28:42 |
Ask15:28:42 |
Capitalización de mecado |
Dividendo A. |
P/E Ratio |
|
62.31EUR
|
-2.15%
|
1
Volumen de negocios: 62.82 |
61.98Volumen de oferta: 168 |
62.95Tamaño/ Volumen/ Formato de Ask: 168 |
37.09 mil millonesEUR |
- |
- |
Descripción de negocio
Edwards Lifesciences is the global leader in the science of heart valves and hemodynamic monitoring. Driven by a passion to help patients, the company partners with clinicians to develop innovative technologies in the areas of structural heart disease and critical care monitoring that enable them to save and enhance lives.
Consejo de gestión & Consejo de supervisión
| CEO |
| Bernard J. Zovighian |
| Consejo de gestión |
| Scott B. Ullem, Donald E. Bobo Jr., Todd J. Brinton, Daveen Chopra, Dirksen J. Lehman, Jean-Luc Lemercier, Wayne Markowitz, Christine Z. McCauley, Joseph Nuzzolese |
| Consejo de supervisión |
| Michael A. Mussallem, Kieran T. Gallahue, Leslie S. Heisz, Martha H. Marsh, Nicholas J. Valeriani, Paul A. LaViolette, Ramona Sequeira, Steven R. Loranger, Bernard J. Zovighan |
Datos de la empresa
| Nombre: |
Edwards Lifesciences Corp. |
| Dirección: |
One Edwards Way,Irvine, California 92614, USA |
| Teléfono: |
+1-949-250-2500 |
| Fax: |
- |
| E-mail: |
-
|
| Internet: |
www.edwards.com/ |
| Industria: |
Biotechnology |
| Sector: |
Biotechnology |
| Subsector: |
Biotechnology |
| Fin del año financiero: |
31/12 |
| Acciones de libre circulación: |
83.04% |
| Fecha de OPI: |
03/04/2000 |
